Iterum Therapeutics plc | Business Contracts

Iterum Therapeutics plc 2021 Inducement Equity Incentive Plan, as amended (Filed With SEC on November 10, 2022)

Share Option Cancellation Agreement, dated July 7, 2022, between Iterum Therapeutics plc and Judith M. Matthews (Filed With SEC on August 12, 2022)

Description of Registrant's Securities (Filed With SEC on March 12, 2021)

Form of Placement Agency Agreement (Filed With SEC on October 27, 2020)

Amended and Restated 2018 Equity Incentive Plan, as amended (Filed With SEC on November 10, 2022)

2015 Equity Incentive Plan, as amended (Filed With SEC on November 10, 2022)

Share Option Cancellation Agreement, dated July 7, 2022, between Iterum Therapeutics plc and Corey N. Fishman (Filed With SEC on August 12, 2022)

Consulting Agreement, dated May 25, 2022, between Iterum Therapeutics International Limited and Dr. Michael Dunne (Filed With SEC on August 12, 2022)

Employment Terms by and between Iterum Therapeutics US Limited and Dr. Sailaja Puttagunta dated October 27, 2021 (Filed With SEC on March 28, 2022)

Consulting Agreement dated February 21, 2021 between Iterum Therapeutics International Limited and Dr. Michael Dunne (Filed With SEC on May 14, 2021)

Share Award Letter dated February 17, 2021 issued by Iterum Therapeutics plc to Dr. Michael Dunne and accepted by Dr. Michael Dunne on February 21, 2021 (Filed With SEC on May 14, 2021)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 16, 2021)

Securities Purchase Agreement, dated as of February 9, 2021, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on March 12, 2021)

Form of Securities Purchase Agreement, dated February 9, 2021, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on February 11, 2021)

Form of Placement Agent Warrant (Filed With SEC on February 11, 2021)

Form of Underwriter Warrant (Filed With SEC on February 5, 2021)

Amended and Restated Underwriting Agreement, dated February 3, 2021 (Filed With SEC on February 5, 2021)

Securities Purchase Agreement, dated as of October 22, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on November 16, 2020)

Form of Pre-Funded Warrant (Filed With SEC on October 27, 2020)

Form of Securities Purchase Agreement (Filed With SEC on October 27, 2020)

Form of Placement Agent Warrant (Filed With SEC on October 27, 2020)

Form of Warrant (Filed With SEC on October 27, 2020)

Form of Securities Purchase Agreement (Filed With SEC on October 21, 2020)

Form of Placement Agent Warrant (Filed With SEC on October 21, 2020)

Form of Pre-Funded Warrant (Filed With SEC on October 21, 2020)

Form of Warrant (Filed With SEC on October 21, 2020)

Form of Placement Agency Agreement to be entered into by and between Iterum Therapeutics plc and H.C. Wainwright & Co., LLC (Filed With SEC on October 21, 2020)

Form of Rights Certificate (Filed With SEC on August 6, 2020)

Securities Purchase Agreement, dated as of June 30, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on August 6, 2020)

Securities Purchase Agreement, dated as of June 3, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on August 6, 2020)

Form of Securities Purchase Agreement, dated June 30, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on July 1, 2020)

Form of Placement Agent Warrant (Filed With SEC on July 1, 2020)

Form of Warrant (Filed With SEC on July 1, 2020)

Form of Securities Purchase Agreement, dated June 3, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on June 4, 2020)

Form of Placement Agent Warrant (Filed With SEC on June 4, 2020)

Form of Warrant (Filed With SEC on June 4, 2020)

First Amendment to Loan and Security Agreement, dated as of January 16, 2020, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics International Limited, Iterum... (Filed With SEC on January 17, 2020)

Form of Investor Rights Agreement, to be dated as of the Closing Date, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics International... (Filed With SEC on January 17, 2020)

Form of Indenture (including form of note), to be dated as of the Closing Date, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics... (Filed With SEC on January 17, 2020)

Securities Purchase Agreement, dated as of January 16, 2020, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics International Limited,... (Filed With SEC on January 17, 2020)

Iterum Therapeutics plc (41)